VBI Vaccines Inc/BC Diluted Shares Outstanding (Weighted Average)
VBI Vaccines Inc/BC reported Diluted Shares Outstanding (Weighted Average) of 24.58 million shares for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2024-05-15
- VBI Vaccines Inc/BC weighted average number of shares outstanding, diluted for the quarter ending 2024-03-31 was 24.58M shares, a 185.59% increase year-over-year.
- VBI Vaccines Inc/BC weighted average number of shares outstanding, diluted for the quarter ending 2023-12-31 was 23.77M shares, a 176.10% increase year-over-year.
- VBI Vaccines Inc/BC weighted average number of shares outstanding, diluted for the quarter ending 2023-09-30 was 21.17M shares, a 145.88% increase year-over-year.
- VBI Vaccines Inc/BC weighted average number of shares outstanding, diluted for the quarter ending 2023-06-30 was 8.61M shares, a 0.00% change year-over-year.
- VBI Vaccines Inc/BC weighted average number of shares outstanding, diluted for fiscal 2023 was 15.57M shares, a 80.90% increase from fiscal 2022.
- VBI Vaccines Inc/BC weighted average number of shares outstanding, diluted for fiscal 2022 was 8.61M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2024-03-31 | 24.58M shares 10-Q · filed 2024-05-15 | 24.18M shares derived: average of 2 quarters · filed 2024-05-15 | 23.17M shares derived: average of 3 quarters · filed 2024-05-15 | 19.53M shares derived: average of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | 23.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 22.47M shares derived: average of 2 quarters · filed 2024-04-16 | 17.85M shares derived: average of 3 quarters · filed 2024-04-16 | 15.57M shares 10-K · filed 2024-04-16 |
| 2023-09-30 | 21.17M shares 10-Q · filed 2023-11-14 | 14.89M shares derived: average of 2 quarters · filed 2023-11-14 | 12.84M shares 10-Q · filed 2023-11-14 | 11.75M shares derived: average of 4 quarters · filed 2024-05-15 |
| 2023-06-30 | 8.61M shares 10-Q · filed 2023-08-14 | 8.61M shares 10-Q · filed 2023-08-14 | 8.61M shares derived: average of 3 quarters · filed 2024-05-15 | 8.61M shares derived: average of 4 quarters · filed 2024-05-15 |
| 2023-03-31 | 8.61M shares 10-Q · filed 2024-05-15 | 8.61M shares derived: average of 2 quarters · filed 2024-05-15 | 8.61M shares derived: average of 3 quarters · filed 2024-05-15 | 8.61M shares derived: average of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | 8.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 8.61M shares derived: average of 2 quarters · filed 2024-04-16 | 8.61M shares derived: average of 3 quarters · filed 2024-04-16 | 8.61M shares 10-K · filed 2024-04-16 |
| 2022-09-30 | 8.61M shares 10-Q · filed 2023-11-14 | 8.61M shares derived: average of 2 quarters · filed 2023-11-14 | 8.61M shares 10-Q · filed 2023-11-14 | |
| 2022-06-30 | 8.61M shares 10-Q · filed 2023-08-14 | 8.61M shares 10-Q · filed 2023-08-14 |